FDA Warns Consumers About Common Off-Label Autism Therapy

FDA Warns Consumers About Common Off-Label Autism Therapy

Like any medical intervention, HBOT carries risks, according to the FDA, including mild effects such as ear pressure or sinus pain all the way to very serious adverse effects such as paralysis and embolisms. Oxygen, feeding fire the way it does

4
Like
Save

Comments

Write a comment

*